These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16412822)

  • 1. Effect of different hemodialysis regimens on genomic damage in end-stage renal failure.
    Schupp N; Stopper H; Rutkowski P; Kobras K; Nebel M; Bahner U; Vienken J; Heidland A
    Semin Nephrol; 2006 Jan; 26(1):28-32. PubMed ID: 16412822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis.
    Fragedaki E; Nebel M; Schupp N; Sebekova K; Völkel W; Klassen A; Pischetsrieder M; Frischmann M; Niwa T; Vienken J; Heidland A; Stopper H
    Nephrol Dial Transplant; 2005 Sep; 20(9):1936-43. PubMed ID: 15919695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New approaches for the treatment of genomic damage in end-stage renal disease.
    Schupp N; Schmid U; Heidland A; Stopper H
    J Ren Nutr; 2008 Jan; 18(1):127-33. PubMed ID: 18089459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between different treatment modalities and genomic damage of end-stage renal failure patients.
    Kobras K; Schupp N; Nehrlich K; Adelhardt M; Bahner U; Vienken J; Heidland A; Sebekova K; Stopper H
    Kidney Blood Press Res; 2006; 29(1):10-7. PubMed ID: 16582572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation.
    Stopper H; Treutlein AT; Bahner U; Schupp N; Schmid U; Brink A; Perna A; Heidland A
    Nephrol Dial Transplant; 2008 Oct; 23(10):3272-9. PubMed ID: 18469307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic damage and malignancy in end-stage renal failure: do advanced glycation end products contribute?
    Sebeková K; Wagner Z; Schupp N; Boor P
    Kidney Blood Press Res; 2007; 30(1):56-66. PubMed ID: 17261927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products: specific fluorescence changes of pentosidine-like compounds during short daily hemodialysis.
    Fagugli RM; Vanholder R; De Smet R; Selvi A; Antolini F; Lameire N; Floridi A; Buoncristiani U
    Int J Artif Organs; 2001 May; 24(5):256-62. PubMed ID: 11420874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end products in renal failure.
    Thornalley PJ
    J Ren Nutr; 2006 Jul; 16(3):178-84. PubMed ID: 16825015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily haemodialysis improves indices of protein glycation.
    Floridi A; Antolini F; Galli F; Fagugli RM; Floridi E; Buoncristiani U
    Nephrol Dial Transplant; 2002 May; 17(5):871-8. PubMed ID: 11981076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of peripheral DNA damage by alkaline comet assay in maintenance hemodialysis subjects with hepatitis C infection.
    Horoz M; Bolukbas C; Bolukbas FF; Kocyigit A; Aslan M; Koylu AO; Gumus M; Celik H; Koksal M
    Mutat Res; 2006 Apr; 596(1-2):137-42. PubMed ID: 16458331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study for comparison of reticulocyte-micronulei with lymphocyte-micronuclei in human biomonitoring.
    Stopper H; Hempel K; Reiners C; Vershenya S; Lorenz R; Vukicevic V; Heidland A; Grawe J
    Toxicol Lett; 2005 Apr; 156(3):351-60. PubMed ID: 15763634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of relative blood volume-controlled hemodialysis on blood pressure and volume status in hypertensive patients.
    Dasselaar JJ; Huisman RM; de Jong PE; Burgerhof JG; Franssen CF
    ASAIO J; 2007; 53(3):357-64. PubMed ID: 17515729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of increasing dialysis dose in overweight hemodialysis patients on quality of life: a 6-week randomized crossover trial.
    Wang W; Tonelli M; Hemmelgarn B; Gao S; Johnson JA; Taub K; Manns B;
    Am J Kidney Dis; 2008 May; 51(5):796-803. PubMed ID: 18436090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress, sister chromatid exchanges and apoptosis in the pathogenesis of lymphocytopenia in ESRD patients.
    Pernice F; Floccari F; Nostro L; Caccamo C; Belghity N; Mantuano S; Romeo A; Barilla' A; Aloisi C; Ruello A; Frisina N; Buemi M
    J Nephrol; 2006; 19(5):613-20. PubMed ID: 17136690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance.
    Gugliucci A; Mehlhaff K; Kinugasa E; Ogata H; Hermo R; Schulze J; Kimura S
    Clin Chim Acta; 2007 Feb; 377(1-2):213-20. PubMed ID: 17118352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of advanced glycation end products and chronic complications in ESRD treated by dialysis.
    Meerwaldt R; Zeebregts CJ; Navis G; Hillebrands JL; Lefrandt JD; Smit AJ
    Am J Kidney Dis; 2009 Jan; 53(1):138-50. PubMed ID: 19036487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change.
    Lindsay RM; Heidenheim PA; Nesrallah G; Garg AX; Suri R;
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):952-9. PubMed ID: 17699312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic damage in chronic renal failure--potential therapeutic interventions.
    Stopper H; Schupp N; Klassen A; Sebekova K; Heidland A
    J Ren Nutr; 2005 Jan; 15(1):81-6. PubMed ID: 15648013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.